Shreyas S Vasanawala, MD
Diagnostic Radiology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 4
Offices
4 locations · Lpch Medical Group Div of Lucile · Stanford Health Care
Looking this up.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Vasanawala’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A81282 · Current
Licensed to practise in California · since 2002 · expires 2028-12-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$3,722 in 2024
Medicaid paid $3,722 for 371 billed services this clinician did in 2024, up to 52 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Radiologic examination, chest; single view | 327 | $3,273 |
| X-ray of abdomen, 1 view | 44 | $448 |
| 2024 | 371 | 2 | 52 | $3,722 |
| 2023 | 769 | 8 | 60 | $14,061 |
| 2022 | 395 | 2 | 37 | $3,893 |
| 2021 | 233 | 3 | 33 | $3,279 |
| 2020 | 226 | 2 | 34 | $2,178 |
| 2019 | 83 | 1 | 27 | $828 |
| 2018 | 202 | 4 | 22 | $13,248 |
See the largest Medicaid services in earlier years
2023
| Radiologic examination, chest; single view | 545 | $5,246 |
| Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences | 47 | $3,374 |
| Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences | 32 | $2,448 |
| X-ray of abdomen, 1 view | 91 | $926 |
| Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material | 14 | $881 |
| Computed tomography, thorax, diagnostic; without contrast material | 12 | $673 |
| Radiologic examination, chest; 2 views | 16 | $295 |
| ECHO EXAM OF ABDOMEN | 12 | $217 |
2022
| Radiologic examination, chest; single view | 380 | $3,621 |
| ECHO EXAM OF ABDOMEN | 15 | $271 |
2021
| Radiologic examination, chest; single view | 202 | $1,925 |
| Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences | 13 | $1,170 |
| X-ray of abdomen, 1 view | 18 | $184 |
2020
| Radiologic examination, chest; single view | 206 | $1,972 |
| X-ray of abdomen, 1 view | 20 | $206 |
2019
| Radiologic examination, chest; single view | 83 | $828 |
2018
| Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences | 45 | $4,993 |
| Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material | 32 | $3,939 |
| Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences | 28 | $3,288 |
| Radiologic examination, chest; single view | 97 | $1,028 |
Money from drug and device companies
$336 in 2025
| 2025 | 1 | 4 | None | $336 |
| 2024 | 3 | 7 | $4,000 | $4,596 |
| 2023 | 2 | 6 | None | $501 |
| 2022 | 1 | 1 | $425 | $425 |
| 2021 | 3 | 6 | $3,280 | $3,354 |
| 2019 | 2 | 10 | $5,500 | $6,057 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ge Healthcare | None | $336 | 4 payments
|
See all 4 published payments
| Ge Healthcare | Meals · 2025-12-04 | None | $107 |
| Ge Healthcare | Meals · 2025-10-02 | None | $41 |
| Ge Healthcare | Meals · 2025-09-30 | None | $145 |
| Ge Healthcare | Meals · 2025-05-16 | None | $43 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $4,596
| Bracco Diagnostics | Vueway (Gadopiclenol) | $4,000 | 2 payments
|
| Ge Healthcare | None | $374 | 3 payments
|
| Siemens Medical Solutions USA | Naeotom Alpha | $222 | 2 payments
|
2023: $501
| GE HealthCare | None | $323 | 5 payments
|
| Siemens Medical Solutions USA | Naeotom Alpha | $178 | 1 payment
|
2022: $425
| Teleflex | Urolift System | $425 | 1 payment
|
2021: $3,354
| Ge Healthcare | None | $2,430 | 4 payments
|
| Teleflex | Urolift System | $850 | 1 payment
|
| Siemens Medical Solutions USA | None | $74 | 1 payment
|
2019: $6,057
| Bayer HealthCare Pharmaceuticals | Eovist | $5,917 | 8 payments
|
| Ge Healthcare | None | $140 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| GE HEALTHCARE · Mr Research Study · 2025 | Their institution | $1,069,426 |
| GE HEALTHCARE · Streamlined Mri Protocol Execution Using Automatic Image Quality Assessment and Fast Operator Feedback · 2022 | Their institution | $682,035 |
| Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2023 | Their institution | $671,348 |
| GE HEALTHCARE · Mr Research Study · 2024 | Their institution | $606,787 |
| GE HEALTHCARE · Mr Ai Study · 2023 | Their institution | $291,235 |
| GE HEALTHCARE · Wireless Receiver Coil Transponders for Mri · 2019 | Their institution | $205,927 |
| Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2024 | Their institution | $121,884 |
| Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2025 | Their institution | $106,975 |
| GE HEALTHCARE · Ai Mr · 2020 | Their institution | $101,042 |
| GE Healthcare · Smart Imaging High-Value High-Throughput Diagnostic Using Mri With Machine Learning · 2020 | Their institution | $100,000 |
| GE HEALTHCARE · Mri Technology Development/Evaluation · 2023 | Their institution | $88,385 |
| GE HEALTHCARE · Smart Imaging: High-Value High-Throughput Diagnostic Using Mri With Machine Learning · 2022 | Their institution | $50,000 |
| GE HEALTHCARE · Smart Imaging: High-Value High-Throughput Diagnos · 2021 | Their institution | $50,000 |
| Novartis Pharmaceuticals Corporation · An International Prospective Open-Label, Multi-Center, Randomized Phase III Study Comparing [177lu] Lu-Psma-617 Versus Observation To Delay Castration Or Disease Recurrence in Adult Male Patients With Psma Positive Oligometastatic Prostate Cancer (Ompc) · 2025 | Their institution | $31,250 |
| GE Healthcare · Tiger Team Pediatric Mri · 2020 | Their institution | $3,000 |
| Novartis Pharmaceuticals Corporation · An Open-Label, Randomized, Phase III Study Comparing 177lu-Psma-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (Mhspc) · 2022 | Their institution | $1,152 |
Professional record
- NPI
- 1285703660
- Licence
- CA A81282California A81282: Current · expires 2028-12-31
- Trained
- Stanford University School of Medicine, 2001
- Group
- Lpch Medical Group Div of Lucile · Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085P0229X (2085P0229X); Diagnostic radiology (2085R0202X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2006-11-07
- NPI last updated
- 2024-04-05
- NPI record certified
- 2024-04-05
This is when the NPI record was last certified, not a medical board exam.